Skip to main content
Log in

Emtricitabine and tenofovir DF a worthy pair in the US, UK

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Brogan AJ, Everhard F, Talbird SE, Hutt E.Cost-effectiveness of tenofovir/emtricitabine compared with other NRTI pairs in treatment-naive adults with HIV infection in the USA. 9th International Congress on Drug Therapy in HIV Infection: abstr. P309, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  2. Brogan AJ, Everhard F, Talbird SE, Hutt E, Zimovetz E.NRTI backbone pairs for treatment-naive adults with HIV infection: a UK economic evaluation. 9th International Congress on Drug Therapy in HIV Infection: abstr. P306, 9 Nov 2008. Available from: URL: http://www.hiv9.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emtricitabine and tenofovir DF a worthy pair in the US, UK. Pharmacoecon. Outcomes News 569, 6 (2009). https://doi.org/10.2165/00151234-200905690-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905690-00012

Keywords

Navigation